Teresa Brophy Bair - 18 Oct 2021 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Chief Legal Officer
Signature
Teresa Bair
Issuer symbol
KURA
Transactions as of
18 Oct 2021
Net transactions value
$0
Form type
4
Filing time
19 Oct 2021, 17:13:05 UTC
Previous filing
05 Aug 2021
Next filing
18 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +192,000 $0.000000 192,000 18 Oct 2021 Common Stock 192,000 $17.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares vest on the one year anniversary of the vesting commencement date, and 1/48th of the shares vest in 36 monthly installments thereafter.